Mar Vista Investment Partners LLC Sells 1,905 Shares of Stryker Corporation $SYK

Mar Vista Investment Partners LLC cut its holdings in shares of Stryker Corporation (NYSE:SYK) by 2.2% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 82,957 shares of the medical technology company’s stock after selling 1,905 shares during the period. Stryker comprises approximately 2.7% of Mar Vista Investment Partners LLC’s holdings, making the stock its 18th largest holding. Mar Vista Investment Partners LLC’s holdings in Stryker were worth $30,667,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Clayton Financial Group LLC acquired a new position in Stryker during the third quarter valued at approximately $26,000. Elevation Point Wealth Partners LLC acquired a new stake in shares of Stryker in the 2nd quarter valued at approximately $28,000. Kilter Group LLC bought a new position in shares of Stryker in the second quarter valued at $29,000. Howard Hughes Medical Institute acquired a new position in Stryker during the second quarter worth $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in Stryker during the third quarter worth $34,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SYK. BTIG Research boosted their price objective on shares of Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Citizens Jmp upgraded Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price target on the stock in a research note on Friday, December 19th. Citigroup reaffirmed a “market outperform” rating on shares of Stryker in a report on Friday, January 30th. Barclays reiterated an “overweight” rating and issued a $469.00 price target on shares of Stryker in a research note on Monday, February 2nd. Finally, Sanford C. Bernstein raised their price objective on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research report on Friday, January 9th. Thirteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $426.47.

Insider Transactions at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the sale, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. This represents a 9.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 5.90% of the stock is currently owned by insiders.

Stryker Price Performance

Shares of SYK opened at $384.16 on Thursday. The business has a 50-day moving average of $361.87 and a 200-day moving average of $369.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. The company has a market capitalization of $147.02 billion, a price-to-earnings ratio of 45.73, a price-to-earnings-growth ratio of 2.23 and a beta of 0.87. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $404.87.

Stryker (NYSE:SYK) last released its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter in the prior year, the firm posted $4.01 EPS. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.